Progyny, Inc.
General ticker "PGNY" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.9B (TTM average)
Progyny, Inc. follows the US Stock Market performance with the rate: 34.3%.
Estimated limits based on current volatility of 2.0%: low 27.28$, high 28.41$
Factors to consider:
- Total employees count: 856 (+25.9%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Market competition, Regulatory and compliance, Acquisition/divestiture risks, Economic downturns and volatility, Cybersecurity threats
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [19.43$, 32.56$]
- 2026-12-31 to 2027-12-31 estimated range: [20.92$, 34.55$]
Financial Metrics affecting the PGNY estimates:
- Positive: with PPE of 37.5 at the end of fiscal year the price was neutral
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: 4.60 < Operating profit margin, % of 6.62
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 7.31
- Positive: 8.77 < Operating cash flow per share per price, % of 9.54
- Positive: -11.23 < Investing cash flow per share per price, % of -7.22
- Positive: -51.61 < Industry operating profit margin (median), % of -17.21
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Negative: 69.38 < Shareholder equity ratio, % of 69.51 <= 81.92
Short-term PGNY quotes
Long-term PGNY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,088.60MM | $1,167.22MM | $1,288.66MM |
| Operating Expenses | $1,026.41MM | $1,099.77MM | $1,203.38MM |
| Operating Income | $62.18MM | $67.45MM | $85.28MM |
| Non-Operating Income | $8.51MM | $15.75MM | $10.15MM |
| Income(Loss) | $70.69MM | $83.20MM | $95.43MM |
| Taxes | $8.65MM | $28.87MM | $36.91MM |
| Net Income(Loss)* | $62.04MM | $54.34MM | $58.52MM |
| Stockholders Equity | $553.43MM | $422.06MM | $516.04MM |
| Assets | $756.62MM | $607.10MM | $742.43MM |
| Operating Cash Flow | $188.81MM | $179.10MM | $210.19MM |
| Capital expenditure | $3.64MM | $5.41MM | $18.41MM |
| Investing Cash Flow | $-200.53MM | $195.79MM | $-159.01MM |
| Financing Cash Flow | $-11.07MM | $-309.88MM | $-99.36MM |
| Earnings Per Share** | $0.65 | $0.59 | $0.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.